Identification of molecular markers of inflammatory mediators in posterior laryngitis due to laryngopharyngeal reflux and evolution with PPI treatment
Phase of Trial: Phase II/III
Latest Information Update: 15 Jan 2008
At a glance
- Drugs Rabeprazole (Primary)
- Indications Laryngopharyngeal reflux
- Focus Pharmacodynamics
- 15 Jan 2008 Status changed from recruiting to completed.
- 05 Nov 2005 New trial record.